Introduction {#Sec1}
============

Endothelial cells are the gate keepers of vascular inflammatory signaling. In acute inflammation, the endothelium attracts and guides leukocytes to the site of affliction. Chronic endothelial activation promotes atherosclerosis development and aneurysm formation. Endothelial cells sense danger-associated molecules (DAMPs) by pattern recognition receptors, like toll-like receptors (TLR1-9) of the innate immune system. On the long run, this may promotes vascular disease as cholesterol and other unspecific pro-atherosclerotic agents are also sensed by TLRs \[[@CR31]\]. In the acute setting of inflammation, however, TLR signaling is needed to facilitate the local endothelial response to pathogens.

TLR signaling is complex and of the several elements involved, the MyD88- and TRIF-pathways are of particular relevance. MyD88 activates nuclear factor (NF)-κB, which induces inflammatory cytokine expression. The TRIF pathway stimulates interferon regulatory factor-3 (IRF3), in addition to NF-κB and induces type I interferons \[[@CR23]\]. Importantly, TLR3 does not really activate MyD88 and therefore only stimulates the TRIF pathway \[[@CR27]\].

On the basis of their subcellular localization, TLRs are divided in two groups. TLR1, 2, 4, 5 and 6 are expressed on the cell surface where they recognize lipid structures and, in the case of TLR5, the protein flagellin. TLR3, 7, 8 and 9 reside intracellularly and sense nucleic acids within the endolysosomal compartment \[[@CR28]\]. Their intracellular localization is potentially a consequence of the fact that TLR binding to nucleic acids requires an acidic environment \[[@CR20]\]. Thus, circulating nucleic acids have to be delivered to intracellular TLRs. The mechanisms underlying this transport are, however, not completely characterized but obviously have to involve endocytosis of the nucleic acid. At least two major endocytotic pathways operate in parallel in endothelial cells: uptake through clathrin-coated pits and internalization by membrane rafts \[[@CR10]\]. Although the concept of membrane rafts is still vigorously debated, there is consensus that proteins of the flotillin family are enriched in this fraction and are markers of rafts \[[@CR32]\].

Interestingly, despite their ubiquitous expression and high conservation, the physiological function of flotillins is far from clear and their role in the endothelium has, to our knowledge, not yet been determined. The flotillin protein family consists of flotillin-1 and 2 (also called reggies) which homo- and hetero-oligomerize \[[@CR2], [@CR37]\]. Despite some other functions \[[@CR4], [@CR32]\], flotillins have been linked to endocytosis and vesicular trafficking but also to signaling \[[@CR6], [@CR8], [@CR14], [@CR15], [@CR24], [@CR33], [@CR36], [@CR38]\]. For example, flotillins modulate epidermal growth factor receptor auto-phosphorylation and activation of downstream target molecules \[[@CR1]\].

Considering their prominent positioning on lipid rafts, we here hypothesize that flotillins contribute to vascular inflammatory signaling in response to the endosomal TLR3 and studied this in human umbilical vein endothelial cells (HUVECs).

Materials and methods {#Sec2}
=====================

Materials {#Sec3}
---------

Human fibronectin was purchased from BD Biosciences (Heidelberg, Germany). DAPI, chloroquine, carrageenan, dextran sulfate, lipopolysaccharide (*E. coli*), filipin III and methyl-β-cyclodextrin from Sigma-Aldrich. MG132 was from Merck, Leupeptin and pepstatin from Applichem. Poly-I:C high molecular weight, Poly-I:C-rhodamine and lipoteichoic acid (*S. aureus*) were from InvivoGen (San Diego, USA). Phenylmethylsulfonyl fluoride (PMSF) was from Applichem.

Cell culture {#Sec4}
------------

Four batches of HUVECs were purchased from Lonza (Walkersville, MD). Cells were cultured in EBM (Lonza, Walkersville, MD), supplemented with 8 % FCS, bovine brain supplement and human recombinant EGF, penicillin (50 U/ml) and streptomycin (50 μg/ml). Cells of passage two to four were used throughout the study and all experiments were performed at least in three different batches. Cells were stimulated in EBM with 1 % FCS, except thapsigargin treatment it was performed in EBM with 4 % FCS. Concentration and timing of the experiments are described in the figure legend. For poly-I:C-rhodamine uptake, cells were stimulated for 3 h (0.5 µg/ml) washed with phosphate buffered saline and subsequently images were acquired by confocal microscopy (LSM 510, Zeiss).

siRNA, shRNA and plasmid transfection {#Sec5}
-------------------------------------

For shRNA treatment, endothelial cells were infected with lentiviral particles according to Addgene "plKO.1 Protocol" (<http://www.addgene.org/tools/protocols/plko/>). Cells were selected with puromycin (0.5 µg/ml). The shFlot-1A target sequence was: 5′-CAGAGAAGUCCCAACUAAUUA-3′, for shFlot-1B 5′-CUGCUUGGCUUUAGCUUCCCG-3′ and for m-shFlot-1 CAGGATTACTTACACTCGTTA. Unless otherwise noted, all experiments were performed with shFlot-1A. Target sequence for shFlot-2 was 5′-GUGCAGAGAGAUGCUGACAUU-3′. Control shRNA against green fluorescent protein (shGFP) and shScrambled (shScr) were from Addgene. For siRNA treatment, endothelial cells (80--90 % confluent) were transfected with GeneTrans II according to the instructions provided by MoBiTec (Göttingen, Germany). All siRNAs (Stealth RNAi) were from Invitrogen. siScrambled (siScr) was used as a negative control. Plasmid overexpression was achieved with the neon electroporation system (Invitrogen). The plasmids pFlot-1-GFP-N1 and pFlot-2-GFP-N1 have been described earlier \[[@CR30]\]. Control plasmid mCherry-N1 was from Clontech. Two siRNAs and shRNAs were used to exclude that unspecific effects of an individual approach mediated the effects observed.

Quantitative RT-PCR {#Sec6}
-------------------

Total RNA was extracted with the RNA Mini Kit (Bio&Sell). cDNA was prepared with SuperScript III reverse transcriptase (Invitrogen) and random hexamer primers. Quantitative real-time PCR was performed with Fast Plus Eva Green Master Mix and ROX as reference dye (Biotium) in an Mx3005 cycler (Stratagene) with primer sequences as follows: VCAM-1 forward primer, 5′-TGTCATCATCTCTTGTACATGTGG-3′, and reverse primer, 5′-GTTTTCTCTTCCTTGAACATCAAG-3′; ICAM-1 forward primer, 5′-CAGTGGGCAA-GAACCTTACCCTAC-3′, and reverse primer, 5′-GTTCAGTGCGGCACGAGAAATTGG-3′; IFNß forward primer, 5′- AGTGTCAGAAGCTCCTGTGGC-3′ and reverse 5′- TGAGGCAGT ATTCAAGCCTCC-3′; CXCL10 forward primer, 5′-TGGCATTCAAGGAGTACCTCTCT-3′ and reverse 5′-CTGATGCAGGTACAGCGTACG-3′, SCARA1 forward primer, 5′- CTC CAT TTA CGA AAG TTC GAC TG-3′ and reverse 5′-ACCAGTACCTTGTCCAAAGTG-3′; SCARA2 forward primer, 5′-AAATCAATGTTCCAAAGCCCAAG-3′ and reverse 5′-ACTGCAGCAAGG AGAAGGAC-3′; SCARA3 forward primer, 5′-TGGATCCGAAAGCCCTGAAC-3′ and reverse 5′-AGAAGGAGCAACTGCCCATC-3′; SCARA4 forward primer, 5′-GAGCGTGAAAATGAA TGGAAGTG-3′ and reverse 5′-AATGCAGATGACAGTACTGTCTC-3′; SCARA5 forward primer, 5′-TCTTCATCTTAGCAGTGTCCAG-3′ and reverse 5′-GCAACGAGTCTGACTGGT TC-3′; SCARB1 forward primer, 5′-CAGCAGGTCCTTAAGAACGTG-3′ and reverse 5′-GTT GTTGTTGAAGGTGATGTTGC-3′; SCARB3 forward primer, 5′-CTATGCTGTATTTGAATC CGACG-3′ and reverse 5′-TACACAGGTCTCCCTTCTTTG-3′; SCARF1 forward primer, 5′-AGGATGAAGCTGCAGGTCTG-3′ and reverse 5′-ACAGGGACCATCCCTTCTTG-3′. Caveolin-1 forward primer-A, 5′-ACGTGGTCAAGATTGACTTTGAAG-3′ and reverse-A 5′-AGA TGTGCAGGAAAGAGAGAATG-3′. Caveolin-1 forward primer-B, 5′-TAGACTCGGAGG GACATCTC-3′ and reverse-B 5′-TCGATCTCCTTGGTGTGCGCGTC-3′. Caveolin-2 forward primer, 5′-TCGCATCTCAAGCTGGGCTTCG-3′ and reverse 5′-TACAAAAGG CATTAAAATCCAGATG-3′. Flotillin-1 forward primer, 5′-AAGCTGCCCCAGGTGGCAGAG G-3′ and reverse 5′-TGTTCTCAAAGGCTTGTGATTCACC-3′. Flotillin-2 forward primer, 5′-AGGGTGAAAAGGTGAAGCAGGTCC-3′ and reverse 5′-TTGGCAGCA ATCTGGGGCAGG-3′. Relative mRNA level of target genes was normalized to polymerase (RNA)II (DNA-directed) polypeptide A (POLR2A) with the primer pair 5′-GCACCACGTCCAATGACAT-3′ and 5′-GTGCGGCTGCTTCCATAA-3′, analyzed by the ΔΔCT method.

Protein isolation and Western blot analysis {#Sec7}
-------------------------------------------

Cells were lysed in buffer containing 10 mmol/l Tris/HCl, pH 8.0, 150 mmol/l NaCl, 10 mmol/l, 5 mmol/l EDTA, 0.5 % Triton X-100, 60 mmol/l N-octylglucoside, supplemented with 40 mg/l PMSF and protease inhibitor mix (antipain, aprotinin, leupeptin, chymostatin, pepstatin, trypsin inhibitor; 2 mg/ml each; all from AppliChem). After determination of protein concentration by Bradford assay, equal amounts of proteins were boiled in Laemmli buffer and separated by SDS-PAGE gel. After transfer of proteins onto nitrocellulose membranes and blocking with Roti-Block (Carl Roth), the following primary antibodies were used: anti-flotillin-1, flotillin-2 both from BD Biosciences (610821, 610384) and Santa Cruz (sc-25506, sc-25507). Caveolin-1 and caveolin-2 from Abnova (MAB2408) and Cell Signaling (8522). The antibody for VCAM-1(sc-8304), ICAM-1(sc-8439) and p65(sc-109) were from Santa Cruz, GAPDH (G8795) from Sigma-Aldrich. IRF-3 (4302) and pIRF-3 (Ser 385) (4947) were from Cell Signaling. PERK (Thr 981) (sc-32577) and eIF2α (Ser52) (sc-101670) from Santa Cruz. Western blot analysis was performed with an infrared-based laser scanning detection system (Odyssey, Licor). The infrared fluorescent-dye-conjugated secondary antibodies were purchased from Licor.

SILAC LTQ-Orbitrap mass spectrometry and detergent-resistant membrane isolation {#Sec8}
-------------------------------------------------------------------------------

Stable isotope labeling of amino acids (SILAC) was performed as described in the manufacturer's protocol from Thermo Scientific. The "SILAC protein quantitation kit---DMEM:F12" was used. Simultaneously to shRNA transduction, knockdown cells were incubated with "heavy" ^13^C~6~[L]{.smallcaps}-lysine + ^13^C~6~^15^N~4~ L-arginin and control shRNA cells with "light" ^12^C~6~[L]{.smallcaps}-lysine + ^12^C~6~^14^N~4~ L-arginin for 9 days. Cell medium was supplemented with dialyzed 10 % FBS, 0.4 % ECGS/H, 10 ng/ml epidermal growth factor receptor, 1 µg/ml hydrocortisone and proline 500 µmol/l. Heavy and light labeled cell lysates were pooled according to their total protein concentration. Detergent-resistant membranes were isolated as reported previously by others \[[@CR17]\] employing a three-step sucrose gradient of 40, 30 and 5 %. Detergent-resistant membranes accumulated according to their density at the interface between the 30 and 5 % sucrose layer after ultracentrifugation. Samples were digested with trypsin (15 h) followed by dithiothreitol (DTT) and iodoacetamide treatment and purified by solid-phase extraction (SPE), subsequently subjected to Orbitrap XL mass spectrometer (Thermo) coupled to a nano-HPLC (Agilent). Chromatography was performed on a C18-reversed phase silica filled column in a 75 μm ID PicoTip emitter (New Objectives) in 60 min HPLC runs using gradients with 0.1 % formic acid from 5 to 50 % acetonitrile following by 90 % wash and 5 % re-equilibration steps. Eluted peptides were analyzed by MS/MS method in positive mode programmed to fragment the top ten most abundant ions using dynamic exclusion with a resolution of 30,000 at 400 Th. Single charged precursor ions were rejected, the fragmentation of peptide ions occurred in the linear ion trap by CID at 35 % collision energy. Fragmentation spectra were extracted from RAW spectra using extract_msn (Thermo) and matched against the human database (Uniprot) containing 20,366 sequences with the Mascot server 2.2 search engine. The search parameters were set as following: 15 ppm deviation on the precursor and 0.6 Da on fragment masses, fixed carbamidomethylation of cysteine, variable oxidation of methionine and one missed cleavage. Only peptides with Mascot scores above the significance threshold of 0.05 were taken into account.

Fluorescence-activated cell sorting (FACS) {#Sec9}
------------------------------------------

For FACS analysis, cells were detached with Versene and incubated with TLR3 or TLR4 antibodies (Abcam) for 45 min by 4 °C. After washing, cells were incubated with the secondary antibody conjugated with Alexa Fluor 488 (45 min, 4 °C). For intracellular staining, cells were permeabilized with Cytofix/Cytoperm (BD Biosience) for 20 min by 4 °C, before the primary antibody was added. Cells were analyzed by the FACS calibur machine (BD Biosciences, Heidelberg, Germany).

Proximity ligation assay (PLA) and total internal reflection fluorescence (TIRF) microscopy {#Sec10}
-------------------------------------------------------------------------------------------

PLA was performed with the Duolink kit as described in the manufacturer's protocol (Duolink II Fluorescence, OLink, Uppsala, Sweden). HUVECs were fixed in phosphate buffered formaldehyde solution (4 %), permeabilized with Triton X-100 (0.2 %), blocked with serum albumin solution (3 %) in phosphate buffered saline and incubated over night with antibodies against caveolin-1 (Abnova) and flotillin-1 (Cell Signaling). After washing, samples were incubated with the respective PLA-probes for 1 h (37 °C), washed and ligated for 30 min (37 °C). After an additional washing, amplification with polymerase was allowed for 100 min (37 °C). The basal plasma membrane was shown by paxillin (BD Bioscience) and the nuclei were stained using DAPI. Images were acquired by Zeiss TIRF System LASOS77 in epifluorescence and TIRF mode, which only illuminates the first 200 nm of the basal compartment of the cell.

Peripheral blood mononuclear cell (PBMC) adhesion {#Sec11}
-------------------------------------------------

2 × 10^4^ HUVECS were seeded on µ-slides (IBIDI VI 0.4) and cultured to 95 % confluence, subsequently stimulated with poly-I:C (10 µg/ml, 5 h) and incubated with PBMC (provided by DRK-Blutspendedienst, Germany, Hessen) for 3 min. To distinguish between attached and non-attached PBMCs, the chamber was subsequently superfused with Hank's buffer containing 0.5 % bovine serum albumin. Starting with an initial flow rate of 0.35 dyn/cm^2^, perfusion was increased to 2, 5, 8 and 15 dyn/cm^2^ every 30 s. Adherent PBMCs were quantified by microscopy (AxioObserver, Zeiss).

Statistics {#Sec12}
----------

Data are expressed as the mean ± SEM. Statistical analyses were performed by student´s *t* test or one-way ANOVA followed by Bonferroni´s multiple comparison test for normally distributed values according to *F* test. For not-normally distributed values, Kruskal--Wallis-Test followed by Dunns correction for the comparison of more than two groups or Mann--Whitney-Test for two independent groups was applied. For paired comparisons of two dependent groups the Mann--Whitney--Wilcoxon-Test was used. Values of *P* \< 0.05 were considered statistically significant.

Results {#Sec13}
=======

Flotillin-1 is essential for poly-I:C-induced inflammatory gene expression {#Sec14}
--------------------------------------------------------------------------

The role of flotillin-1 in TLR-induced signaling in human umbilical vein endothelial cells (HUVEC) was studied by shRNA and TLR signaling was initiated by selective agonists. Activation of TLR3 by polyriboinosinic polyribocytidylic acid (poly-I:C) and of TLR4 by lipopolysaccharide (LPS) induced endothelial inflammatory adhesion molecule expression, whereas the TLR2 ligand lipoteichoic acid had little effect in endothelial cells (Fig. [1](#Fig1){ref-type="fig"}a, b). Knockdown of flotillin-1 decreased the poly-I:C-induced VCAM-1 and ICAM-1 expression (Fig. [1](#Fig1){ref-type="fig"}a, c), whereas flotillin-1 shRNA did not affect LPS-induced inflammatory activation (Fig. [1](#Fig1){ref-type="fig"}b, c). Basal level of VCAM-1 and ICAM-1 was not affected by the control or flotillin-1 shRNA (data not shown).Fig. 1Flotillin-1 is essential for poly-I:C-induced inflammatory gene expression. **a** and **b** Western blot and densitometry for the proteins indicated in HUVEC treated with or without poly-I:C, lipopolysaccharide (LPS) and lipoteichonic acid (LTA, each 10 µg/ml, 3 h) after lentiviral transduction with shRNAs for flotillin-1 (shFlot-1*A* and *B*) or GFP (shGFP) (**c**) qRT-PCR for VCAM-1 relative to RNA polymerase II by 2\^-ΔΔCT in HUVEC stimulated with (each 10 µg/ml, 90 min) or without LPS and poly-I:C after transduction with shRNAs for flotillin-1 (shFlot-1*A* and *B*), GFP (shGFP) or a scrambled shRNA (shScr). *N* = 3; \**p* \< 0.05 with vs. without poly-I.C, ^\#^ *p* \< 0.05 shGFP vs. shFlot

Flotillin-1 is involved in poly-I:C-induced IRF-3 signaling {#Sec15}
-----------------------------------------------------------

Endothelial poly-I:C-induced signaling activates the TRAF-MyD88 pathway as well as the transcription factor IRF-3, which facilitates type I interferon expression \[[@CR27]\]. Down-regulation of flotillin-1 also attenuated the poly-I:C-induced expression of interferon β (IFNβ) as well as of the interferon related cytokine CXCL10 (Fig. [2](#Fig2){ref-type="fig"}a). As expected, TLR4 activation, which predominantly signals through MyD88 only induced a weak activation of the IRF pathway and importantly, this response was not affected by down-regulation of flotillin-1. In contrast, the poly-I:C-induced phosphorylation of IRF-3 was attenuated by down-regulation of flotillin-1 (Fig. [2](#Fig2){ref-type="fig"}b), whereas the LPS-induced stabilization of the MyD88-downstream element p65 of the NFκB-pathway was not changed (Fig. [2](#Fig2){ref-type="fig"}c). Collectively, these findings suggest that flotillin-1 is involved in TLR3 but not in TLR4-mediated signaling.Fig. 2Flotillin-1 is involved in poly-I:C-induced IRF-3 signaling. **a** qRT-PCR for the IRF-3-inducible genes IFNβ and CXCL10 in HUVEC stimulated with or without poly-I:C and LPS (each 10 µg/ml, 90 min) after transduction with shRNAs for flotillin-1 (shFlot-1*A* and *B*), GFP (shGFP) or a scrambled shRNA (shScr). **b** and **c** Western blot analysis for the proteins indicated of nuclear extracts from HUVEC stimulated with poly-I:C (**b**, 10 µg/ml) and LPS (**c**, 10 µg/ml) for the times indicated after transduction with shRNA for flotillin-1 (shFlot-1) or GFP (shGFP). pIRF-3 indicated anti-phospho-IRF3 (phospho-Ser 385). Topo-1: DNA-topoisomerase. *N* = 4; \**p* \< 0.05

The human flotillin family consists of two proteins with 46 % amino acid homology, which form homo- and hetero-oligomers \[[@CR2], [@CR37]\]. Importantly, flotillin-2 shRNA had no effect on poly-I:C-induced adhesion molecule expression despite the fact that the shRNA drastically decreased the expression of flotillin-2 (Fig. [3](#Fig3){ref-type="fig"}a, b). These findings suggest that only flotillin-1 but not flotillin-2 is involved in TLR3 signaling.Fig. 3Poly-I:C-induced adhesion of peripheral blood mononuclear cells requires flotillin-1. **a** qRT-PCR and **b** Western blot with densitometry for the gene indicated relative to the house-keeping gene RNA polymerase II or GAPDH in HUVECs stimulated with poly-I:C (10 µg/ml, **a**: 90 min, **b**: 180 min) after transduction with shRNA against flotillin-1 (shFlot-1), flotillin-2 (shFlot-2) or shGFP *N* = 4, *p* \< 0.05. **c** and **d** Representative microscopic image (**c**) and statistical analysis (**d**) of peripheral blood mononuclear cell (PBMCs) adhering during flow of 0.35 and 15 dyn/cm^2^ on poly-I:C stimulated (10 µg/ml, 5 h) HUVECs transduced as indicated. **e** and **f** Western blot of the proteins indicated in HUVECs electroporated with plasmids coding for mCherry (pmCherry-N1), flotillin-2-GFP (pFlot-2-GFP-N1) and flotillin-1-GFP (pFlot-1-GFP-N1) stimulated with or without poly-I:C (10 µg/ml, 180 min) and with (**e**) or without (**f**) transduction of shGFP or shFlot-1. *N* = 4, \**p* \< 0.05, *ns* not significant

Flotillin-1 is required for poly-I:C-induced adhesion of peripheral blood mononuclear cells on HUVEC {#Sec16}
----------------------------------------------------------------------------------------------------

To determine the functional consequence of flotillin-1 depletion on poly-I:C signaling in HUVEC, adhesion assays were carried out with human peripheral blood mononuclear cells (PBMCs), mainly comprising lymphocytes and monocytes. The effect of flotillin shRNA on adhesion paralleled that on VCAM-1 expression: down-regulation of flotillin-1, but not flotillin-2, drastically reduced PBMC adhesion on poly-I:C stimulated HUVEC (Fig. [3](#Fig3){ref-type="fig"}c, d).

Overexpression of flotillin-1 restores poly-I:C-induced VCAM-1 induction {#Sec17}
------------------------------------------------------------------------

As shRNA and siRNA in general may interfere with TLR3 signaling, experiments to test the specificity of our findings were carried out. Transfection of HUVECs with an shRNA-resistant flotillin-1-GFP expression plasmid restored normal poly-I:C-induced VCAM-1 induction (Fig. [3](#Fig3){ref-type="fig"}e). Interestingly, also in the absence of shRNA, overexpression of flotillin-1-GFP, but not flotillin-2-GFP promoted the poly-I:C-induced expression of VCAM-1 (Fig. [3](#Fig3){ref-type="fig"}f).

Flotillin-1 is involved in the uptake of poly-I:C-rhodamine {#Sec18}
-----------------------------------------------------------

For inflammatory cells, it has been suggested that TLRs differ in their cellular localization. Whereas TLR4-induced signaling occurs at the plasma membrane, TLR3, which is thought to mainly localize to endosomes, requires uptake of its ligands for signaling \[[@CR23], [@CR43]\]. Similarly, also in HUVECs, as determined by fluorescence-activated cell sorting (FACS), TLR4 was present on the surface of the cells whereas TLR3 was only detectable after permeabilization, indicative of an intracellular localization (Fig. S1). As flotillins are assumed to contribute to endocytosis and vesicular trafficking, it was determined whether flotillin-1 shRNA affects the transport of rhodamine-labeled poly-I:C. In control cells, the poly-I:C-rhodamine fluorescence was readily detectable after 3 h stimulation, whereas in shFlot-1 cells, poly-I:C uptake was greatly reduced (Fig. [4](#Fig4){ref-type="fig"}a, b). This suggests that flotillin-1 is involved in the trafficking of poly-I:C and thus in the delivery of dsRNA to its intracellular receptors.Fig. 4The scavenger receptor SCARA4 mediates poly-I:C-induced signaling. **a** and **b** Original laser scanning microscopic images (**a**) and quantification (**b**) from HUVEC transduced with shGFP and shFlot-1 after incubation with poly-I:C-rhodamine (*red*, 0.5 µg/ml, 180 min). Nuclei are counterstained with DAPI (*blue*). **c** q-RT-PCR for the genes indicated relative to the house-keeping gene RNA polymerase II in HUVECs. **d** Representative Western blot and densitometry for the genes indicated in HUVECs transduced with shGFP or shFlot-1 after pretreatment with and without the class A scavenger receptor inhibitor dextran sulfate (10 µg/ml, 5 min) and subsequent stimulation with poly-I:C (10 µg/ml, 180 min). *N* = 4, \**p* \< 0.05. **e** Western blot analysis and densitometry for the proteins indicated and qRT-PCR for SCARA3 (*left bottom*) and SCARA4 (*right bottom*) in HUVECs treated with scrambled siRNA or two different siRNAs (−A and −B) against SCARA3 (*left*, siSCARA3) or SCARA4 (*right*, siSCARA4) followed by stimulation with poly-I:C (10 µg/ml, 180). *N* = 4, \**p* \< 0.05

The scavenger receptor SCARA4 mediates poly-I:C-induced signaling in HUVEC {#Sec19}
--------------------------------------------------------------------------

To facilitate endocytosis, uptake and delivery of poly-I:C to endosomes and thus to TLR3, cell surface receptors are required that bind the extracellular dsRNA. This task is carried out by scavenger receptors (SR). So far, eight structurally unrelated SR subclasses (A-H) \[[@CR39]\] have been characterized of which subclasses A and B are thought to be the most relevant ones. We therefore screened the expression of SRs by qRT-PCR and found several of them to be highly expressed in HUVECs (Fig. [4](#Fig4){ref-type="fig"}c). To narrow down the selection to the ones relevant for poly-I:C binding, the effect of an SR A antagonist was tested. The SR A antagonizing polysaccharide polymer dextran sulfate \[[@CR25]\] prevented the poly-I:C-induced VCAM-1 induction (Fig. [4](#Fig4){ref-type="fig"}d). This, in combination with the qRT-PCR screening data, make SCARA3 and SCARA4 likely candidates for poly-I:C binding. Subsequent siRNA experiments revealed that indeed the knockdown of SCARA4 but not SCARA3 prevented the poly-I:C-induced VCAM-1 induction (Fig. [4](#Fig4){ref-type="fig"}e). Thus, poly-I:C at the plasma membrane may bind to SCARA4, which could subsequently be internalized to transport poly-I:C to TLR3 in a process requiring flotillin-1.

Flotillin-1 maintains structural proteins of caveolae {#Sec20}
-----------------------------------------------------

To address the mechanism by which flotillin-1 interacts with the endocytotic pathways, proteomics was carried out. For this, the effect of flotillin shRNA on the protein composition of the detergent-resistant membrane protein fraction of HUVECs (Fig. S2a) was determined by stable isotope labeled amino acids (SILAC) in combination with ESI-Orbitrap mass spectrometry analysis. shRNA against the individual flotillins not only reduced their abundance in the detergent-resistant fraction, but also affected other proteins (Figs. [5](#Fig5){ref-type="fig"}a, S2b--d and Tables [1](#Tab1){ref-type="table"}, S1--S3). Importantly, shRNA against flotillin-1 reduced the abundance of the structural caveolae proteins caveolin-1, cavin-1 and cavin-2 in the detergent-resistant fraction.Fig. 5Flotillin-1 maintains caveolin-1 protein which is required for the poly-I:C response. **a** Subset of SILAC-mass spectrometric analyses on the effect of shFlot-1 on protein abundance in the detergent-resistant membrane fraction of HUVECs. **b** Exemplary Western blot and densitometry for the proteins indicated of HUVECs transduced with shGFP or shFlot-1 or transfects with scrambled siRNA (siScr) or caveolin-1 siRNA (siCav-1) with and without stimulation with poly-I:C (10 µg/ml, 180 min), \**p* \< 0.05, *n* = 4. **c** Proximity ligation assays for flotillin-1 and caveolin-1 interaction (*red*) in HUVECs transduced with shGFP or shFlotillin-1. *Down* total internal reflection fluorescence microscopy (TIRF) image, *up* epifluorescence. Cells were counterstained with paxillin (*green*) and DAPI (*blue*). **d** and **e** Exemplary Western blot and densitometry for the proteins indicated of HUVECs transduced with shGFP or shFlot-1 with and without stimulation of thapsigargin 3.3 µmol/l. *N* = 4 \**p* \< 0.05Table 1Flotillin-1 SILAC LTQ-Orbitrap-MS: list of proteins significantly down-regulated (\>20 %) by shFlot-1 relative to shGFP in the detergent-resistant membrane of HUVECs (*n* = 3)ProteinAccessionScoreMean heavy/lightSEMFlot1Flotillin-1O759551,9340.100.04Flot2Flotillin-2Q142541,7940.110.05CAV1Caveolin-1Q031351,3620.620.05CAVIN1Cavin-1Q6NZI21,1110.690.08ERLN2Erlin-2O949057930.580.10VDAC2Isoform 2 of voltage-dependent anion-selective channel protein 2P45880-26230.740.01SERPHSerpin H1P504545120.630.04PGK1Phosphoglycerate kinase 1P005584190.550.11CAVIN2Cavin-2O958104180.670.06LDHBL-lactate dehydrogenase B chainP071953330.590.18CATDCathepsin DP073392680.730.04VINCVinculinP18206-21670.660.04

Flotillin-1 maintains caveolin-1 expression which is essential for the poly-I:C response {#Sec21}
----------------------------------------------------------------------------------------

As caveolin-1, cavin-1 and cavin-2 are essential for caveolae function \[[@CR16], [@CR18]\], it is plausible that the inhibitory effect of flotillin-1 shRNA on poly-I:C signaling is a consequence of caveolae dysfunction. Indeed, siRNA against caveolin-1, similar to flotillin-1 shRNA, attenuated caveolin-1 expression which was accompanied by decreased poly-I:C-induced VCAM-1 expression (Fig. [5](#Fig5){ref-type="fig"}b). It appears that flotillin-1 maintains caveolin-1 level, as also in whole cell lysates, flotillin-1 shRNA but not flotillin-2 depletion decreased caveolin-1 protein levels in HUVECs and in mouse lung endothelial cells (Figs. [5](#Fig5){ref-type="fig"}b, S3a, b). Also, overexpression of caveolin-1 in shFlot-1 cells failed to recover caveolin-1 level (Fig. S3c).Caveolin-1 siRNA, in contrast, had no effect of flotillin-1 expression (Fig. [5](#Fig5){ref-type="fig"}b). Finally, flotillin-1 shRNA had no effect on caveolin-2 protein levels (Fig. S3g) which further supports a selective role of flotillin-1 for caveolin-1 expression.

Proximity ligation assay and total internal reflection (TIRF) microscopy of the plasma membrane revealed a close co-localization of caveolin-1 with flotillin-1 predominantly within the cell (Fig. [5](#Fig5){ref-type="fig"}c), suggesting that flotillin-1 interferes with caveolin-1 stability. However, the inhibitory effect of flotillin-1 shRNA on caveolin-1 was not prevented by inhibition of the proteasome or the lysosomal pathway (Fig. S3d, e). Also, flotillin-1 shRNA had only a small, yet significant, effect on caveolin-1 mRNA expression (Fig. S3f) suggesting rather attenuated translation and/or misfolding caveolin-1 protein. Disturbing of endoplasmic reticulum (ER) protein formation and maturation leads to the ER stress also termed unfolded protein response (URP), a situation in which ER-localized translation is attenuated. ER stress activates a signaling pathway which includes phosphorylation of the type I ER transmembrane kinase PERK which then directly phosphorylates the eukaryotic initiation factor 2 eIF2α. Importantly, increased PERK and eIF2α phosphorylation were present in shFlot-1 cells (Fig. [5](#Fig5){ref-type="fig"}d), indicating that loss of flotillin-1 results in ER stress, which then may block caveolin-1 translation. Accordingly, treatment of HUVEC with the ER-stress inducer thapsigargin similarly abolished caveolin-1 expression independent of the expressions level of flotillin-1 (Fig. [5](#Fig5){ref-type="fig"}e). In keeping with this, after down-regulation of flotillin-1 even plasmid-based overexpression of caveolin-1 failed to restore the normal protein levels (Fig. S3c).

To substantiate our hypothesis that caveolae are required for poly-I:C signaling, cholesterol-perturbing agents were studied. Although this approach is unspecific, interfering with caveolae function by methyl-beta-cyclodextrin, filipin and carrageenan attenuated the poly-I:C--induced VCAM-1 expression (Fig. S4). Collectively, flotillin-1 is required for caveolin-1 expression in endothelial cells, and lack of caveolin-1 upon down-regulation of flotillin-1 results in an inhibition of caveolae function which is required for poly-I:C signaling.

Discussion {#Sec22}
==========

In this study, we determined the contribution of flotillin-1 to endothelial inflammatory TLR signaling. Flotillin-1 was required for poly-I:C-dependent signaling through TLR3 but not for LPS-mediated signaling through TLR4. Flotillin-1, but not flotillin-2 facilitated TLR3-mediated IRF activation and the subsequent expression of adhesion molecules which leads to leukocyte attachment. As potential mechanism we identified that flotillin-1 maintains the cellular caveolin-1 protein content.

The exact mechanisms by which extracellular dsRNA and poly-I:C are bound on the cell surface and gain entry into the cell are poorly characterized. Scavenger receptors of class A and B are likely candidates due to their cell surface expression and ability to bind nucleic acids \[[@CR9], [@CR11]\]. Our screen revealed that both scavenger receptor classes are expressed in HUVECs and particularly SCARA4 appeared to be important for poly-I:C-mediated signaling. Thus, it can be inferred that SCARA4 acts as carrier for poly-I:C and delivers the molecule to TLR3. The process presumably requires flotillin-1, as the uptake of poly-I:C was reduced after flotillin-1 down-regulation. Our data suggest, however, that flotillin-1 acts only indirectly by maintaining caveolin-1, which forms the structural correlate of the endocytotic pathway of relevance here.

Caveolae are highly abundant in the endothelium and make up to 20 % of the surface of the cell \[[@CR16]\]. One of their major functions is the clathrin-independent endocytosis, a process which requires caveolin proteins \[[@CR18]\]. Caveolin-1 acts as a scaffolding protein that facilitates caveolae formation and endocytosis \[[@CR22]\]. In endothelial cells, caveolin-1 has complex roles in signaling due to its multiple functions. Translocation of enzymes like endothelial NO synthase into caveolae reduced their activity \[[@CR34]\], whereas translocation of receptors and kinases into caveolae can lead to the formation of signaling hot spots \[[@CR42]\]. Finally, caveolae-mediated uptake of receptors results in termination of signaling or facilitates intracellular signaling \[[@CR3]\].

Our data demonstrate that in the case of poly-I:C-induced signaling, the latter is true: Cholesterol perturbing reagents which induce caveolae dysfunction blocked the poly-I:C-mediated induction of adhesion molecules, and caveolin-1 siRNA had a similar effect. These findings mimic the effect of down-regulation of flotillin-1. The reason for this was that flotillin-1 maintained caveolin-1, cavin-1 and cavin-2 in the detergent-resistant membrane fraction, generally considered containing caveolae and other membrane rafts. It should be emphasized that we did not intend to directly characterize caveolae or lipid rafts by the proteomics approach in the present study but rather sought for the effect of depletion of flotillins on the detergent-resistant membrane fraction. We chose this approach as detergent-free isolation of lipid rafts and caveolae in our hands were too variable for proteomics which is naturally limited in the number of samples applicable and in sensitivity. Thus, although we could clearly identify that flotillin-1 impacts on caveolar proteins, we cannot make statements concerning the consequence on caveolae at the plasma membrane itself. Subsequent Western blots revealed that flotillin-1 knock-down resulted in a global depletion of caveolin-1 from the cell, which may suggest that already at an early stage of membrane integration of caveolin-1, flotillin-1 might be of relevance. The combination of proximity ligation assay and TIRF technique in our study supports this view: although flotillins-1 co-localized with caveolin-1 to some extent, this effect was largely restricted to intracellular compartments around the nucleus, but not frequent at the plasma membrane. Our finding of a very restricted intracellular interaction of flotillin-1 and caveolin-1 may also help to explain why by means of membrane isolation or conventional LSM technique, interactions of the two proteins were not reported \[[@CR12], [@CR13]\]. The fact that the proteins can be co-immuno-precipitated \[[@CR41]\] does not contradict this notion as it is probably not possible to successfully solubilize membrane rafts without disrupting antibody-antigen binding. Thus, in immunoprecipitation studies usually whole membrane patches are being pulled down.

In the present study, we found no evidence that flotillin-1 prevents the degradation of caveolin-1 as neither lysosomal nor proteasomal inhibitors restored caveolin-1 level in flotillin-1 knock-down cells. Although this contrasts a previous observation in an epithelial cell line \[[@CR40]\] it points to a function of flotillins-1 in caveolin-1 synthesis. Depletion of flotillin-1 in HUVEC induced a small decrease in caveolin-1 mRNA expression which, however, is not sufficient to explain the almost complete lack of caveolin-1 protein under this condition. Therefore, we assumed that the lack of flotillins-1 prevents de novo synthesis of caveolin-1 at the level of translation. The homeostasis of the endoplasmic reticulum (ER) is important for maturation of newly synthesized secretory and transmembrane proteins. Conditions interfering with the function of ER are called ER stress. ER stress is induced by accumulation of unfolded proteins (unfolded protein response, UPR) or by excessive protein demand caused by viral infection (ER overload response, EOR) \[[@CR19], [@CR21]\]. Activation of ER stress sensors such as PERK kinase or EIF2α reduces the ER workload and induces expression of chaperons. Our findings that flotillin-1 depletion induces ER stress signaling and that caveolin-1 translation itself is sensitive to ER stress explain its reduced level in shFlot-1 HUVECs.

The question remains how flotillin-1 depletion induces ER-stress. Flotillin-1 is involved in endosomal sorting, trafficking from and towards the plasma membrane and the transport to the ER and Golgi \[[@CR29], [@CR35]\]. We speculate that the lack of flotillin-1 disturbs vesicular trafficking but further studies will be needed to clarify this aspect.

Flotillin-2 can stabilize flotillin-1 \[[@CR2], [@CR13], [@CR15]\] and also in HUVEC, flotillin-2 shRNA reduced the flotillin-1 protein expression to some extent. Despite this, loss of flotillin-2 often does not phenocopy the loss of flotillins-1 \[[@CR7]\]. For example, ERK signaling is increased in flotillin-2 knockout mice whereas depletion of flotillin-1 decreased it \[[@CR5]\]. Also in the present study, depletion of flotillin-2 reduced flotillin-1 expression to some extent but was without effect on signaling. Potentially, the residual flotillin-1 expression was sufficient to maintain signaling. Our flotillin-1 overexpression experiments at least exclude that the anti-inflammatory effect of flotillin-1 shRNA was mediated by excess flotillin-2 exhibiting aberrant binding.

It is a limitation of the present study that only cultured cells were studied but not knockout mice. In fact, such experiments were carried out by us, but in keeping with the overall very mild phenotype in the flotillin-1 global knockout mice \[[@CR7], [@CR26]\], we failed to detect a difference in caveolin-1 expression between wild type and flotillin-1 global knockouts (C. Fork. unpublished observations). Thus, it was important to exclude that the altered responses in the cells were not a consequence of an unspecific interference of the shRNAs and siRNAs with TLR signaling. The fundamental experiments were performed in two different shRNAs with similar results and overexpression of flotillin-1 restored normal poly-I:C-induced VCAM-1 expression. To exclude that the lack of effect in the global knockout mice was a consequence of a specific function of flotillin-1 in HUVEC, the key experiments, i.e. the attenuation of poly-I:C induced VCAM-1 induction by flotillin-1 shRNA, was also carried out in murine lung endothelial cells, with similar results. We therefore conclude that so far unidentified compensations beyond the scope of our present study are operative in global flotillin-1 knockout mouse.

Conclusion {#Sec23}
==========

We have identified that flotillin-1 is an important mediator of TLR3 signaling in HUVEC. In these cells, acute loss of flotillin-1 leads to attenuation of caveolar protein abundance. As caveolar proteins turn out to be required for TLR3 signaling, flotillin-1 might represent a novel target for anti-inflammatory therapy.
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